Valuation : Alkem Laboratories Limited

Market Cap 637B 6.7B 5.77B 5.41B 4.94B 9.28B 9.35B 64.16B 24.96B 323B 25.15B 24.6B 1,070B P/E 2027 *
27.8x
P/E 2028 * 24.1x
Enterprise Value 624B 6.56B 5.65B 5.3B 4.84B 9.09B 9.16B 62.84B 24.45B 316B 24.63B 24.09B 1,048B EV / Sales 2027 *
3.74x
EV / Sales 2028 * 3.28x
Free-Float
37.56%
Yield 2027 *
0.93%
Yield 2028 * 1.04%
1 day-0.50%
1 week-0.88%
Current month-7.80%
1 month-7.80%
3 months-0.22%
6 months-2.99%
Current year-3.70%
1 week 5,281
Extreme 5281
5,406.5
1 month 5,175
Extreme 5175
5,774.5
Current year 5,075
Extreme 5075
5,933.5
1 year 5,075
Extreme 5075
5,933.5
3 years 3,447
Extreme 3447
6,439.9
5 years 2,828
Extreme 2828
6,439.9
10 years 1,455
Extreme 1455
6,439.9
Manager TitleAgeSince
President - -
President - -
Director of Finance/CFO - 2024-01-31
Director TitleAgeSince
Director/Board Member 44 2013-08-08
Director/Board Member 63 2008-02-10
Director/Board Member 45 2019-11-10
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%-0.88%+0.05%+45.57% 6.7B
-1.52%-7.23%+57.90%+108.72% 1,031B
-0.82%-2.63%+50.05%+64.43% 641B
+0.37%-3.06%+21.87%+74.48% 453B
-2.25%-6.78%+32.71%+32.65% 349B
+4.23%+1.77%+27.04%+44.44% 290B
-1.29%-2.10%+0.05%+11.20% 252B
-0.59%-3.15%+49.83%+67.70% 232B
+0.09%-1.87%-19.57%-53.90% 201B
+0.45%-0.27%+29.84%+91.34% 181B
Average -0.21%-2.72%+24.98%+48.66% 363.65B
Weighted average by Cap. -0.53%-3.97%+36.85%+64.90%

Financials

2027 *2028 *
Net sales 167B 1.76B 1.51B 1.42B 1.3B 2.43B 2.45B 16.81B 6.54B 84.68B 6.59B 6.45B 280B 186B 1.95B 1.68B 1.58B 1.44B 2.71B 2.73B 18.7B 7.28B 94.18B 7.33B 7.17B 312B
Net income 23.14B 243M 209M 197M 179M 337M 340M 2.33B 907M 11.74B 913M 893M 38.86B 27.15B 285M 246M 231M 211M 396M 398M 2.73B 1.06B 13.77B 1.07B 1.05B 45.59B
Net Debt -13.08B -137M -118M -111M -101M -191M -192M -1.32B -512M -6.63B -516M -505M -21.96B -28.06B -295M -254M -238M -218M -409M -412M -2.83B -1.1B -14.23B -1.11B -1.08B -47.11B
Logo Alkem Laboratories Limited
Alkem Laboratories Ltd. is an India-based pharmaceutical company engaged in the development, manufacturing, and sale of pharmaceutical products. The Company operates in a single business segment-Pharmaceuticals. It produces branded generics, generic drugs, active pharmaceutical ingredients (APIs), and nutraceuticals, which it markets in India and international markets. It has a portfolio of approximately 800 brands in India and maintains a presence in over 40 international markets, with the United States being its key focus market. Its offerings include therapies, prescription (Rx) products, and Alkem generics. Its therapy offerings cover multiple medical fields, including anti-infectives, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory care, rheumatology, and urology. The Company’s subsidiaries include Ascend Laboratories (Pty) Ltd, Pharmacor Pty Limited, Alkem Laboratories Corporation, and others.
Employees
19,346
Date Price Change Volume
26-09-01 5,294.00 -0.67% 46,381
26-08-31 ₹5,329.50 -0.48% 120,023
26-08-28 ₹5,355.00 +0.66% 231,100
26-08-27 ₹5,320.00 +0.31% 166,838
26-08-26 ₹5,303.50 -1.20% 44,001
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
5,329.50INR
Average target price
5,948.55INR
Spread / Average Target
+11.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALKEM Stock